Home » Topics » BioWorld Science

BioWorld Science
RSS

Constellation Pharmaceuticals patents EZH2 inhibitors

Dec. 11, 2019

Xeris reports in-clinic stage data from phase II trial of RTU glucagon

Dec. 11, 2019

Three phase III trials of tralokinumab in atopic dermatitis meet endpoints

Dec. 11, 2019

GenSight reports on REALITY registry study in support of Lumevoq

Dec. 11, 2019

The anti-CD33/CD3 BiTE AMG-673 shows promise as treatment for relapsed/refractory AML

Dec. 11, 2019

First-in-human study of LOXO-305 confirms it as a potent anti-BTK agent for B-cell malignancies

Dec. 11, 2019

Pfizer gives details on the discovery of novel noncovalent modulator of hemoglobin

Dec. 11, 2019

Anti-BCMA CAR-T candidate C-CAR088 shows early clinical efficacy

Dec. 11, 2019

Implicit Bioscience presents phase I data for IC-14 in motor neuron disease

Dec. 11, 2019

Intrathecal AVXS-301 shows promise in preclinical models of ALS

Dec. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...